Mediwound receives complete response letter from u.s. fda for nexobrid biologics license application

Company remains committed to working with fda toward a potential approval for this important therapy company remains committed to working with fda toward a potential approval for this important therapy
MDWD Ratings Summary
MDWD Quant Ranking